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Abstract 
Background: The babA2 gene along with the cagA and vacA of Helicobacter pylori has been considered as a risk fac-
tor for the disease outcome in certain populations. This study was aimed to understand the role of babA2 of H. pylori 
with the background of cagA and vacA in disease manifestations in Indian sub population.
Methods: A total of 114 H. pylori strains isolated from duodenal ulcer (DU) (n = 53) and non-ulcer dyspepsia (NUD) 
patients (n = 61) were screened for the prevalence of these virulence markers by PCR. The comparative study of IL-8 
production and apoptosis were done by co-culturing the AGS cell line with H. pylori strains with different genotypes. 
Adherence assay was performed with babA2 positive and negative strains. Two isogenic mutants of babA2 were con-
structed and the aforesaid comparative studies were carried out.
Results: PCR results indicated that 90.6 % (48/53), 82 % (50/61) and 73.6 % (39/53) strains from DU patients were 
positive for cagA, vacA, and babA2, respectively. Whereas the prevalence of these genes in NUD subjects were 70.5 % 
(43/61); 69.8 % (37/53), and 65.6 % (39/61), respectively. Although adherence to AGS cells was comparable among 
strains with babA2 positive and negative genotypes, but the triple positive strains could induce highest degree of IL-8 
production and apoptosis, followed by the cagA−/vacA−/babA2+ strains and triple negative strains, respectively. The 
wild type strains showed significantly higher IL-8 induction as well as apoptosis in ex vivo than its isogenic mutant of 
babA2.
Conclusion: PCR study demonstrated that there was no significant association between the distribution of babA2 
genotype or of triple positive strains and disease outcome in this sub population. The adherence assay showed that 
there was no significant difference in the extent of adherence to AGS cells among babA2 positive and negative strains. 
But the ex vivo study indicated that the triple positive or even the babA2 only positive strains are involved in increased 
virulence. The wild type strains also exhibited increased virulence compared to the babA2 mutant strains. This incon-
sistency demonstrated that bacterial genotype along with host genetic polymorphisms or other factors play impor-
tant role in determining the clinical manifestation of H. pylori infections.
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Background
Helicobacter pylori is a Gram-negative, genetically 
diverse spiral bacteria that infects more than half of the 
population worldwide [1]. Infection with H. pylori is 
associated with duodenal ulcer (DU) or gastric ulcer, gas-
tritis, and gastric adenocarcinoma [2]. About 65–70  % 
of the Indian population is infected with H. pylori [3, 4]. 
15–20 % of overall infected population develop gastric or 
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The genome of various H. pylori strains demonstrates 
significant genetic diversity. Genetic variation in spe-
cific virulence genes of H. pylori may participate in the 
pathogenic process of H. pylori infection in the stomach, 
thereby contributing to the variable risk of diverse clini-
cal outcomes. So, in addition to the host immunological 
factors and environmental factors, another important 
reason for the diverse clinical outcomes is the differences 
in virulence factors among H. pylori strains [6].
Cytotoxin-associated gene (cagA) was the first reported 
gene that varies in H. pylori strains and is considered as 
a marker for the presence of the cag pathogenicity island 
(cag PAI), which includes a number of other genes asso-
ciated with increased virulence [7–9]. About one-half to 
two-thirds of US and European strains carry the cag PAI 
and is associated with overt disease. In contrast, cag PAI 
is distributed among most of the Asian strains, irrespec-
tive of disease status. In India the asymptomatic individ-
uals also carry the cag PAI [10]. It was found that most 
of the H. pylori strains in Indian subcontinent have cagA 
typeA and any particular type of cagA is not associated 
with disease outcome [11].
Some H. pylori strains can produce vacuoles in epi-
thelial cells by the action of VacA protein which consists 
of a signal region (s1 or s2) and a middle region (m1 or 
m2). Strains harboring the s1m1 mosaic combination are 
said to be more cytotoxically potent than the strains with 
s1m2 genotype, while s2m2 strains do not secrete vacu-
olating cytotoxin [12]. In Western countries, H. pylori 
strains with s1m1 genotype usually also carry the cag 
pathogenicity island (cag PAI) and are more significantly 
associated with the disease than those strains which don’t 
have this cag PAI [7]. In Indian population, the strains 
with s1m1 genotype are predominant [13]. It concludes 
that the diseases are multi-factorial and thereby we need 
to identify other bacterial virulence factors which play 
important role in diseases manifestation.
It is generally known that bacterial adherence to the 
gastric epithelium is the first critical stage of coloniza-
tion by H. pylori in the human stomach [14]. The blood 
group antigen binding adhesin (BabA) is one of the major 
outer membrane proteins of H. pylori that binds to the 
fucosylated Lewisb blood group antigens on the gastric 
epithelium and plays a key role in facilitating bacterial 
colonization to the stomach [15, 16]. It has been hypoth-
esized that the adherent bacteria may be more success-
fully able to transfer their products to the host cells. 
Thus, a higher bacterial density coupled with more capa-
ble delivery of bacterial products to the host cells may 
provoke a stronger inflammatory response. It has been 
already shown that H. pylori is able to commence non-
specific immune responses [17]. H. pylori has various 
adhesins, including blood group antigen binding adhesin 
(BabA), which binds to the Lewis B (Leb) antigen [15, 
18]. H. pylori adhesin-mediated colonization is multi-
factorial and no single adhesin may be essential, although 
adherence of this bacteria to the gastric epithelium is a 
compulsory early step in colonization and renders H. 
pylori 100–1000 times more resistant to antibiotics than 
the non-adherent ones [19]. Blood group antigen bind-
ing adhesin is encoded by a polymorphic gene named 
babA2, while the babA1 allele is non-functional. Gerhard 
et al. [20] in 1999 first demonstrated a positive associa-
tion between a babA2 carrying strain and duodenal ulcer 
(DU) and gastric cancer (GC). Subsequently, a series of 
studies of the association between babA2 gene and pep-
tic ulcer diseases and GC have been performed, but with 
inconsistent or conflicting conclusions [21–24]. However, 
in Asian countries, most of the strains are babA2 positive 
irrespective of disease status [25, 26]. These data clearly 
indicates that the frequency of H. pylori babA2 gene may 
vary geographically and their associations with disease 
outcome also vary accordingly.
Although Indian subcontinent constitutes about the 
1/5th of the world population, but there was not much 
studies about the role of babA2 gene in disease outcome 
from this subcontinent. The contradictory conclusions 
from previous studies and the inadequate information 
from India provided the impetus to study (1) the clinical 
relevance of the babA2 gene by examining its associa-
tion with H. pylori virulence-associated genes and with 
clinical outcome as well as (2) the comparative analysis of 
IL-8 production and apoptosis by co-culturing the AGS 
cell line with Indian H. pylori strains with variant genetic 
makeup.
Results
A total of 185 subjects underwent for endoscopy from 
which 114 H. pylori strains were isolated. The biopsies 
were divided into two groups according to their clinical 
symptoms: duodenal ulcer (DU) and non ulcer dyspep-
sia (NUD). Subjects with abdominal discomfort, acidity, 
loss of appetite but no frank ulceration were considered 
as non-ulcer dyspepsia (NUD) but those have endoscopi-
cally visible duodenal ulceration were considered as duo-
denal ulcer (DU) patients. The strains were isolated from 
53 DU patients (male  =  54  %, median age  =  62  years, 
range 28–85 years) and 61 NUD patients (male = 52 %, 
median age = 67 years, range 27–87 years). The genomic 
DNA was isolated from these strains and was used for 
further downstream PCR-based analysis.
Prevalence of babA2, cagA and vacA
The integrity and specificity of these isolated H. pylori 
DNAs were confirmed by PCR amplification of the ure-
ase gene, which yielded an expected 480  bp amplicon 
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from all the DNAs (data not shown). The distribution 
of babA2 gene in the 114 Indian H. pylori strains were 
studied first using the PCR-based genotyping. The frag-
ment of babA2 was amplified primarily by using forward 
primer nthu_babA2F [26] and reverse primer babA2R 
[20]. PCR assay with these primers yielded an ampli-
con of 832 bp (Fig. 1A) and 60.5 % (69/114) strains pro-
duced positive amplicon for babA2 gene. Another two 
sets of primers (namely babA2F and babA2R; babA2F 
and babA2R607) were used to amplify the babA2 gene 
from the strains that did not give positive amplicon with 
the primary set of primers [20, 27]. PCR with these two 
new combination of primers yielded amplicon of babA2 
fragment (832 and 607  bp respectively) from 3 (72/114, 
Fig.  1B) and 5 (77/114, Fig.  1C) more clinical isolates, 
respectively. Finally, on the basis of the combined results 
with these three sets of primers, our analysis depicted 
that 67.5 % (77/114) Indian H. pylori strains were positive 
for babA2 gene (Table 1).
The cagA and vacA status of these 114 strains were 
determined using the previously described primers and 
protocols [5]. The cagA positive strains produced an 
amplicon of 350 bp (data not shown) and 86 % (98/114) 
strains were positive for cagA (Table 1). The strains that 
were negative for cagA, yielded a 550  bp amplicon for 
cag-empty site using the primers located in the flank-
ing region of the cag PAI. vacA s and m alleles were also 
studied and it was shown that the most potentially toxic 
vacA s1m1 allele was predominantly present in the tested 
strains and it showed a frequency of 71.9 % (82/114).
The babA2 gene was determined among the two groups 
of patients [DU (53) and NUD (61)]. PCR results showed 
that 69.8  % (37/53) strains were babA2 positive in DU 
and 65.6  % (40/61) babA2 positive strains were present 
in NUD subjects (Table 1). The babA2 gene was almost 
equally distributed among strains from DU patients and 
NUDs in this region. So, the prevalence of babA2 in this 
region showed no significant correlation with disease 
outcome. Our study demonstrated that the babA2 geno-
type was predominant among H. pylori strains irrespec-
tive of disease status.
Among the 98 cagA positive strains used in this study, 
41 of 48 DU patients and 40 of 50 NUD individuals pro-
duced a typical ~642-bp amplicons, designated as type A 
by Yamaoka et al. [28] (Table 2). Six strains from DU and 
nine strains from NUD yielded ~756 bp amplicon in PCR 
using the same set of primers and considered as having 
cagA type B/D (Table 2). Two strains (one each from DU 
and NUD) produced a ~810  bp amplicon correspond-
ing to type C (Table 2). No correlation with disease out-
come was found with any of the cagA types. Sequencing 
analysis of the representative strains showed that all of 
them carried Western-CagA-specific sequences (WSS) 
FPLKRHDKVDDLSKV. These strains contained 1–5 
EPIYA motifs in their cagA gene sequence. Sequence 
analysis also revealed that more than 80  % of the cagA 
positive strains carried 3 EPIYA motifs (A-B-C type) at 
the 3′ end of the gene and they were almost equally dis-
tributed between DU and NUD. Similarly, vacA s1m1 
allele was present in almost equal frequencies in DU 
patients and NUDs (Table 1).
The association study of these virulence genes in each 
strain reveals no statistically significant (P  <  0.05) cor-
relation between the distribution of the triple positive 
strains (combined presence of cagA, vacA s1m1 allele 
and babA2) and disease status. Additionally, 84 iso-
lates were classified as type 1 strains (positive for both 
cagA and vacA s1m1) and 61 were found as triple posi-
tive strains among them. These type 1 strains also exhib-
ited an almost uniform distribution among DUs (40/53, 
75.47 %, Table 3) and NUDs (44/61, 72.13 %, Table 3). It 
was found that these 61 triple positive strains distributed 
almost equally in DU (29/53, 54.7  %, Table  3) patients 
and NUDs (32/61, 52.4 %, Table 3). Among the 16 cagA 
Fig. 1 Genotyping of babA2 gene in Indian H. pylori isolates. The 
images shown are from a representative gel electrophoresis of a 
PCR amplification product of babA2 gene from Indian isolates and 
J99 control strain with A nthu_babA2F and babA2R primers [26], B 
babA2F and babA2R primers [20], and C babA2F and babA2R607 
primers [27]. Where lane 1 positive control, lanes 2–10 clinical isolates, 
lane 11 negative control, and lane 12 DNA ladder
Table 1 Prevalence of  the babA2, cagA and  vacA genes 
in different disease groups
Gene Total (n = 114) DU (n = 53) NUD (n = 61)
babA2 77 (67.5 %) 37 (69.8 %) 40 (65.6 %)
cagA 98 (86 %) 48 (90.6 %) 50 (82 %)
vacA s1m1 82 (71.9 %) 39 (73.6 %) 43 (70.5 %)
Table 2 Prevalence of  cagA subtypes in  different disease 
groups
CagA types DU (n = 48) NUD (n = 50)
Type A 41 (85.4 %) 40 (80 %)
Type B/D 6 (12.5 %) 9 (18 %)
Type C 1 (2 %) 1 (2 %)
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negative strains tested, 6 (37.5  %) were found as babA2 
positive strains.
Adherence of H. pylori to the gastric epithelial (AGS) cells is 
independent of babA2
Adherence of H. pylori to the AGS cells was performed as 
described in methods section and was found comparable 
among the strains with babA2 positive and babA2 nega-
tive genotypes (data not shown). It was also observed 
that there was significantly no difference in the ability 
of adherence between the wild type and isogenic babA2 
mutants (data not shown).
Triple positive strains show greater IL‑8 induction in AGS 
cells
Based on the presence or absence of these three viru-
lence genes, the tested strains were divided into four 
groups: (1) triple positive strains (cagA+/vacA+/babA2+), 
(2) cagA+/vacA+/babA2− strains, (3) cagA−/vacA−/
babA2+ strains, and (4) triple negative strains (cag−/
vac−/babA2−). After co-cultured with H. pylori strains 
for 8  h the IL-8 secretion was significantly (P  <  0.05) 
higher from those cells which were infected with the tri-
ple positive strains (827.3 ± 80.88 pg mL−1, n = 3) than 
the cells infected with cagA+/vacA+/babA2− strains 
(523.1  ±  43.84  pg  mL−1, n  =  3, Fig.  2a). Similarly, sig-
nificantly (P < 0.05) higher amount of IL-8 induction was 
recorded when the cells were infected with cagA−/vacA−/
babA2+ strains (462.7 ± 47.81 pg mL−1, n = 3) compared 
to triple negative strains (62.80 ±  2.30 pg mL−1, n =  3, 
Fig. 2b).
babA2 mutant strains show decreased level of IL‑8 
induction in AGS cells
To further establish our data we carried out the IL-8 assay 
in cell culture as described previously by infecting the 
cells with I-121, 135(1) wild type strains and their babA2 
mutants separately. The results indicated that the sig-
nificantly (P < 0.05) higher amount of IL-8 induction was 
recorded from the cells infected with the wild type strains 
(729.18 ± 22.39 and 433.95 ± 12.41 pg mL−1 respectively, 
Fig. 3) rather than its babA2 mutants (465.06 ± 16.19 and 
202.77 ± 12.33 pg mL−1 respectively, Fig. 3).
Triple positive strains trigger more apoptosis in AGS cell 
line
The cell cycle analysis with propidium iodide reveals 
distribution of cells in three major phases of the cell 
cycle (G1 vs. S vs. G2/M, Fig.  4a) and makes it possi-
ble to detect unhealthy cells with fractional DNA con-
tent. The cells in the sub-G0 phase represent apoptotic 
cells. After co-culturing the AGS cells with H. pylori for 
Table 3 Prevalence of the type 1 and triple positive strains 
in different disease groups
Strains Total (n = 114) DU (n = 53) NUD (n = 61)
Type 1 strains 84 (73.7 %) 40 (75.5 %) 44 (72.1 %)
Triple positive strains 61 (53.5 %) 29 (54.7 %) 32 (52.4 %)
Fig. 2 Triple positive strains and even the babA2 positive only strains enhance IL-8 production in AGS cells. In vitro IL-8 production from AGS cells 
co-cultured with randomly selected a triple positive and cagA+/vacA+/babA2− strains, and b cagA−/vacA−/babA2+ and triple negative H. pylori 
strains (MOI is 100) for 8 h. IL-8 from culture supernatant was measured using ELISA as described in “Methods”. Data are expressed as mean ± stand-
ard error of mean (SEM) of 3 experiments in duplicates. *P < 0.05 as compared between groups
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24 h significantly (P < 0.05) higher amount of apoptotic 
cell death was found when the cells infected with triple 
positive strains (64.40 ±  2.485  %, n =  3, Fig.  4aii, b) in 
comparison to the cells infected with cagA+/vacA+/
babA2− strains (47.17  ±  2.916  %, n  =  3, Fig.  4aiii, b). 
Similarly, cagA−/vacA−/babA2+ strains (36.17 ± 1.955 %, 
n = 3, Fig. 4av, c) showed significantly (P < 0.05) higher 
apoptotic cell death than the triple negative strains 
(19.33 ± 2.038 %, n = 3, Fig. 4avi, c) after 24 h infection.
Mutation of babA2 gene causes reduced apoptosis 
in ex vivo
For reconfirming the apoptotic potential of the babA2 
gene we carried out the cell cycle analysis experiment 
in AGS cells by infecting the cells with two wild type 
strains [I-121 and 135 (1) respectively] and their babA2 
deletion mutants as described previously. After 24  h 
of infection it was found that the wild type strains were 
capable of significantly (P  <  0.05) more apoptotic cell 
death (61.8 ± 1.88, 53.56 ± 1.946 % respectively, Fig. 5) 
than their isogenic mutants of babA2 (36.43  ±  1.486, 
24.76 ± 1.328 %, respectively, Fig. 5).
Discussion
Various studies have indicated that the incidence and/
or severity of gastroduodenal pathologies related to H. 
pylori may vary according to geographical regions [27]. 
There is also evidence for the existence of different strains 
of H. pylori with different degrees of virulence indicating 
the variation in the distribution of the different virulence 
attributes of H. pylori in different populations [29–31]. 
The cagA gene was found at a frequency of 86 % among 
the 114 tested strains of this region and this virulence 
marker was found at almost equal frequencies in strains 
from DU patients (90.6  %) and NUD patients (82  %), 
indicating that the prevalence of the cagA gene cannot 
be considered as a key virulence marker for determina-
tion of the clinical status of the host, as has been reported 
in other Indian studies [13, 32]. In our study most of the 
strains have type A cagA without any association in dis-
ease outcome. All the strains used in sequence analysis 
consist of Western-CagA-specific sequence and it is in 
agreement with our previous report [11]. We also found 
that highly virulent s1m1 allele of vacA gene was present 
among 71.9 % of Indian H. pylori strains and presence of 
this allele did not show any correlation with the disease 
outcome (DU = 73.6 %, NUD = 70.5 %) of the host. This 
data is in accord with the previous report having 70  % 
presence of s1m1 allele in Indian H. pylori isolates [5].
Here we found that the Indian H. pylori strains exhib-
ited 67.5 % prevalence of babA2 gene and the babA2 gene 
was uniformly distributed (DU = 69.8 %, NUD = 65.6 %) 
irrespective of disease status. These results indicate 
that, unlike in the Western countries [33], presence of 
babA2 is not associated with clinical outcome in India. 
In our study among 84 double positive strains, 61 were 
found as triple positive. These 61 triple positive strains 
also showed an almost equal distribution in DU (29/53, 
54.7  %) patients and NUDs (32/61, 52.4  %), which is 
inconsistent with the report from few Western countries 
[34].
More recent analyses of babA2 as a virulence marker 
have produced conflicting data on the usefulness of 
babA2 expression in predicting clinical outcome, which 
is most likely dependent on the geographic origin of the 
H. pylori strains. In Portuguese and Thai populations, 
babA2 is not a biomarker for peptic ulcer disease or gas-
tric cancer [35, 36]. However, for strains isolated from 
Germany, Turkey, or northern Portugal, babA2 expres-
sion is associated with the severity of gastric disease [18, 
37, 38]. This inconsistency may be due to the specific 
geographic variation of the circulating bacterial lineages. 
Another explanation for this lack of association may be 
due to the allelic variation of the babA2 gene which was 
studied by Pride et al. [39].
An inflammatory response is one of the main patho-
physiological events in H. pylori mediated infection. 
It has been shown that epithelial cells secrete IL-8 as a 
result of H. pylori infection [40–42]. IL-8 acts as a potent 
chemo-attractant for neutrophils and is thought to play a 
crucial role in H. pylori induced tissue damage [43]. Sev-
eral studies have shown that induction of IL-8 secretion 
from host cells is dependent on the presence of CagA, 
VacA, OMPs (OipA) and LPS [43–46]. In order to see the 
effect of babA2 gene on the IL-8 induction, triple positive 
Fig. 3 Wild type H. pylori strains show higher IL-8 production 
than their isogenic mutant of babA2 in AGS cells. IL-8 from culture 
supernatant was measured using ELISA as described in “Methods”. 
Data are expressed as mean ± standard error of mean (SEM) of 3 
experiments in duplicates. Wild type is denoted with black filled bar 
(◼) and mutants denoted with empty bar (◻). *P < 0.05 as compared 
between groups
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(cagA−/vacA−/babA2+) strains and triple negative strains 
were cultured with AGS cells. The triple positive strains 
induced the highest amount of IL-8 secretion from AGS 
cells, and the double negative strains but with babA2 
gene caused significantly higher amount of IL-8 secretion 
than the triple negative ones (Fig. 2, P < 0.05). Therefore, 
it may be emphasized that the triple positive strains and 
also the presence of babA2 somehow enhances the ability 
of H. pylori to induce IL-8 in the gastric mucosa.
IL-8 secretion and inflammation due to H. pylori infec-
tion lead to epithelial cell damage or apoptosis. Apoptosis 
is a genetically programmed form of cell death which is 
mainly characterized by some distinct morphological and 
molecular features. Microbial pathogens or their prod-
ucts can directly activate the apoptotic pathway which 
plays a role in pathogenesis [47]. It has been reported 
that cagA, and vacA have an effect on H. pylori mediated 
apoptosis [48, 49]. In order to elucidate the role of babA2 
Fig. 4 a–c Triple positive strains and even the babA2 positive only strains cause more apoptosis in AGS cells. a Apoptosis of AGS cells (ai, iv worked 
as controls) co-cultured with different genotypic variant i.e. aii triple positive; aiii cagA+/vacA+/babA2−; av cagA−/vacA−/babA2+; and avi triple 
negative strains of H. pylori strains for 24 h (MOI is 100), stained with propidium iodide and analysed by flow cytometry. These figures are representa-
tive profile of at least three experiments. b, c Graphical representation of  % apoptotic cells (Sub G0 phase) infected with same group of strains were 
expressed as mean ± SEM. *P < 0.05 as compared between groups
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in apoptosis, the triple positive, cagA+/vacA+/babA2−, 
cagA−/vacA−/babA2+ and triple negative strains were 
used independently to infect the AGS cells. It was 
observed that the triple positive strains caused more 
epithelial cell death than the other strains, whereas 
the cagA−/vacA−/babA2+ strains caused significantly 
higher level of apoptosis than the triple negative strains 
(P < 0.05).
As the triple positive strains exhibit highest level of 
IL-8 induction as well as apoptosis that is why we made 
isogenic babA2 mutants of these strains [I-121 and 
135(1) respectively] to reconfirm the role of babA2 in H. 
pylori virulence. The IL-8 induction assay and cell cycle 
analysis by flow cytometry were performed with these 
wild type and mutant strains as described in methods 
section. In agreement, it was found that the wild type 
strains were significantly (P < 0.05) more capable of IL-8 
induction as well as mediating the apoptotic cell death in 
AGS cells (Figs. 3, 5). These data more strongly establish 
the virulence potential of the strains with babA2 positive 
genotype.
It has been already reported that ex vivo IL-8 produc-
tion requires the adherence of viable H. pylori to the AGS 
cells [50], and as the induction of apoptosis and IL-8 
secretion are often linked [51], so it can be said that the 
apoptosis in AGS cells also require the adherence of H. 
pylori. In this study, it was found that the adherence of 
babA2 positive and babA2 negative strains were compa-
rable in AGS cells. In agreement, it was also found that 
the extent of adherence to the AGS cells were compa-
rable between the wild type strains and isogenic babA2 
mutants. This report suggests that although adherence is 
crucial, the babA2 gene products may regulate the IL-8 
secretion and apoptosis by an adherence independent 
manner. H. pylori has at least five different adhesin fac-
tors which use different receptors for adhering on gastric 
epithelial cells [43], suggesting that presence or absence 
of only one of these genes may not affect its adherence 
to gastric cells. Further studies will be required to explain 
what other factors may impact the extent of adherence.
In this report, although it was observed that Indian 
H. pylori strains harbored babA2 gene independent 
Fig. 5 Wild type H. pylori strains cause more apoptotic cell death than their isogenic mutant of babA2 in AGS cells. Apoptosis of AGS cells (i worked 
as controls) co-cultured with different genotypic variant i.e. ii wild type I-121 strain; and iii isogenic babA2 mutant of I-121 strain for 24 h (MOI is 
100), stained with propidium iodide and analysed by flow cytometry. i–iii is only representative profile of at least three experiments carried out 
with I-121 strain and its babA2 mutant. iv Graphical representation of percentage of apoptotic cells (sub G0 phase) infected with two wild type and 
their babA2 mutant strains were expressed as mean ± SEM. Wild type is denoted with black filled bar (◼) and mutants denoted with empty bar (◻). 
*P < 0.05 as compared between groups
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of disease status and also the triple positive strains 
showed no association with disease status, but on the 
other hand, the triple positive strains and even only 
the babA2 positive strains showed more virulence as 
they induced more IL-8 secretion and as well as caused 
more apoptosis in AGS cell line than the triple nega-
tive strains. In accordance, the wild type strains also 
exhibited more capability to induce IL-8 secretion as 
well as apoptosis than their isogenic babA2 mutants in 
the cell culture study. Apparently, it seems that these 
two statements are contradictory. What could be the 
probable reasons? H. pylori is one of the genetically 
diverse bacterial species with regard to genotyping 
[52–54]. Previous reports also suggested that H. pylori 
genotype varies geographically [2, 54]. The polymor-
phisms of some cytokine genes have been found to 
be associated with H. pylori mediated clinical conse-
quences, probably because they modulate the amount 
of cytokine production in response to H. pylori infec-
tion [55]. It was already been established that dietary 
salt intake can play an important role in enhancing the 
likelihood of severe clinical consequences of H. pylori 
mediated infection [56]. Environmental iron level also 
brings about the changes in the composition of the H. 
pylori outer membrane which ultimately influences the 
pattern of clinical outcomes [57]. These above men-
tioned information clearly establish the role of host fac-
tors and environmental factors in the disease outcomes 
of H. pylori mediated infection. Importantly, H. pylori 
toxin gene expression is inconsistent with the general 
phenomenon observed for other pathogenic bacteria, 
that is, that expression of the important toxin genes are 
strongly associated with diseases [58]. The expressions 
of toxin genes by H. pylori are not solely dependent on 
the disease status. So, this result can not lead to the 
underestimation of the role of babA2 gene as a toxin 
gene. The genetic constitution of host may play a criti-
cal role in the successful colonization and ultimately in 
the disease consequences of H. pylori infection. We can 
say that the virulent effect of babA2 gene of H. pylori 
may come into action only after interplay with certain 
host factors. Our results also showed that babA2 gene 
in combination with the presence of cagA and vacA 
s1m1 allele become much more toxic as the triple posi-
tive strains showed highest degree of IL-8 induction 
as well as apoptotic cell death in cell culture study, 
although the PCR-based genotyping results showed 
a uniform distribution of triple positive strains inde-
pendent of disease status. These discrepancies may be 
due to the fact that at the time of H. pylori isolation, the 
NUD people harboring the triple positive strains may 
be at the risk of developing an ulcer disease in future 
which cannot be come into our count.
Conclusion
In conclusion, although the presence of babA2 gene is 
not associated with disease outcome in India, but the 
babA2 positive strains showed more virulence than 
their negative counterparts in ex vivo study. Study also 
indicated that adherence of H. pylori to the gastric epi-
thelial (AGS) cells is not solely dependent on babA2. It 
is evident from this study that bacterial genetic consti-
tution cannot be considered as only responsible factor 
for disease consequences. Certain host factors along 
with bacterial genetic traits may play a crucial role in 
this aspect. Further studies are required to determine 




Biopsy specimens were obtained as described previ-
ously [58] from a total of 185 adult subjects with upper 
gastrointestinal irregularities underwent endoscopy at 
the hospital of the Institute of Post Graduate Medical 
Education and Research, Kolkata, and St John’s Medical 
College Hospital, Bangalore, India, during 2009–2011. A 
detailed case study of each individual was done prior to 
endoscopy. The objective of the study was explained to 
each individual and informed consent was obtained from 
each of them under protocols approved by the ethical 
committees of respective institutes based on the Helsinki 
Declaration. These biopsy samples were transported to 
the laboratory under ice-cold condition in Brucella broth 
(0.6  ml, Difco Laboratories) with glycerol (15  %) and 
stored in −70 °C until culture.
Helicobacter pylori culture
The Brucella broth containing the biopsy samples were 
vortexed in laboratory for 2 min and 200 µl of the mix-
ture was streaked onto brain heart infusion agar (BHIA) 
plate containing horse serum (7  %, Invitrogen, Grand 
Island, NY, USA), IsoVitalex (0.4  %, Becton–Dickinson, 
San Jose, CA, USA), trimethoprim (5  µg  mL−1), vanco-
mycin (6 µg mL−1), polymyxin B (10 µg mL−1) and nali-
dixic acid (8 µg mL−1) (all from Sigma Chemicals, MO, 
USA). These plates were incubated at 37  °C in micro-
aerophilic condition (85 % N2, 10 % CO2, and 5 % O2) for 
3–6 days [10] in a double gas incubator (Heraeus Instru-
ments, Hanau, Germany) and were identified on the basis 
of their typical morphology and urease, oxidase and cata-
lase test result.
DNA extraction and genotyping of cagA, vacA and babA2
Genomic DNA was extracted by using CTAB method 
with phenol/chloroform and isopropanol precipitation 
as described elsewhere [59]. Purified DNAs were stored 
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at −20 ℃ until use. All the PCR reactions were carried 
out in a 25 µl reaction volume containing genomic DNA 
(50  ng), forward and reverse primers (25  pmol), each 
deoxynucleoside triphosphate (0.25  mM each, Roche, 
Berlin, Germany), Taq DNA polymerase (1 U, Genei, 
Bangalore, India), and Mgcl2 (1.5 mM) in a standard PCR 
buffer (Genei, Bangalore, India) for 35 cycles, generally 
under the following reaction condition: 95 ℃ for 1 min, 
55 ℃ for 1  min, and 72 ℃ for a time chosen based on 
the size of the expected amplified fragment (1 min kb−1) 
in a Master Cycler apparatus (Eppendorf, Hamburg, 
Germany). The primers used in this study are listed in 
Table 4.
Generation of babA2 mutant H. pylori
A 832 bp fragment of babA2 was cloned into TOPO TA 
cloning vector (Invitrogen, USA) to generate the plasmid 
pcr2.1: babA2. The isolated plasmid (pCR2.1: babA2) 
DNA was digested with restriction enzyme BsmI (New 
England Biolabs, USA) and ligated with chloramphenicol 
cassette amplified from DR2 plasmid by phusion enzyme 
(Thermo-scientific) to produce plasmid pcr2.1: babA2: 
cmp. This construct was then used to electroporate 
babA2 positive H. pylori cells. Transformed single colo-
nies were sub cultured and screened for the interruption 
of babA2 gene by PCR with babA2F/babA2R set of prim-
ers. Transformed colonies (positive colonies) gave about 
1.6 kb amplicon rather than 832 bp.
IL‑8 assay
All the bacterial strains were cultured in 7  % serum 
containing BHIA plates for 24  h at 37  °C under micro-
aerophilic conditions. In order to obtain ex  vivo IL-8 
secretion from gastric epithelial cells, AGS (human 
gastric adenocarcinoma cell line) cells were plated 
(2.5  ×  105  cells  mL−1) into 24 well plates and cultured 
for 24 h. H. pylori [multiplicity of infection (MOI) of 100] 
were added to cultured cells. After 8 h of infection, IL-8 
levels in the supernatant were assayed in duplicate three 
times using a commercially available specific ELISA kit 
(Genetix, New Delhi, India) following the manufacturer’s 
protocols.
Cell cycle analysis
AGS cells (1 × 106 cells mL−1 in each well) were infected 
with 1 day old H. pylori culture. After 24 h of infection 
cells were fixed in 70  % chilled ethanol and were kept 
at 4 ℃ for further analysis. Prior to analysis cells were 
washed in 2 % fetal bovine serum (FBS) containing PBS 
(pH 7.4) and the cell pellets were stained with propid-
ium iodide (50  µg  mL−1) containing DNase-free RNase 
(0.1 mg mL−1). Cells were then acquired on flow cytom-
eter and the data was analyzed in FACS Diva software 
(Becton–Dickinson, USA).
Adherence assay
AGS cells were cultured to about 70–80 % confluency in 
complete RPMI-1640 medium. AGS cells were washed 
three times with sterile PBS, and RPMI with 10 % FBS 
was added. 24 h old H. pylori culture was washed with 
sterile PBS and suspended in incomplete RPMI. Adher-
ence assay was performed by adding the bacterial cells 
to the AGS monolayer (MOI 100) and incubated for 
2  h [60]. After 2  h of infection unadhered bacterial 
cells were removed and washed three times with ster-
ile PBS. The adhered bacteria were collected in PBS by 
scrapping the cell-line along with the infected bacteria. 
The CFU was determined by plating various serial dilu-
tions of these bacterial suspensions on BHI agar plates. 
All experiments were repeated at least thrice for each 
strain.
Statistical analysis
Each experiment was performed at least thrice in dupli-
cates and results expressed as mean ± standard error of 
the mean (SEM). Statistical analysis was done by T test 
and ANOVA (wherever applicable), using Graph Pad 
Prism software (version 5, Graph Pad Software Inc, La 
Table 4 Primers used in this study for PCR amplification











































Page 10 of 11Ghosh et al. Gut Pathog  (2016) 8:1 
Jolla, CA, USA), P values <0.05 were considered to be 
significant.
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